Zhejiang Qianjiang Biochemical Co., Ltd

SHSE:600796 Stock Report

Market Cap: CN¥5.2b

Zhejiang Qianjiang Biochemical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

Improved Earnings Required Before Zhejiang Qianjiang Biochemical Co., Ltd (SHSE:600796) Stock's 31% Jump Looks Justified

Dec 04
Improved Earnings Required Before Zhejiang Qianjiang Biochemical Co., Ltd (SHSE:600796) Stock's 31% Jump Looks Justified

Returns On Capital Are Showing Encouraging Signs At Zhejiang Qianjiang Biochemical (SHSE:600796)

Dec 03
Returns On Capital Are Showing Encouraging Signs At Zhejiang Qianjiang Biochemical (SHSE:600796)

Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Prospects Need A Boost To Lift Shares

Oct 01
Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Prospects Need A Boost To Lift Shares

Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

May 13
Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

Feb 27
There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

CEO

Zhejiang Qianjiang Biochemical has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Song Zhang
Deputy GM & Vice Chairman2.6yrsCN¥432.00kno data
Qiang Yu
Chairman of the Supervisory Boardno datano data0.00046%
CN¥ 23.9k
Bing Qi Zhu
Employee Supervisorno datano data0.00035%
CN¥ 18.2k
Zhimi Zhou
Director2.6yrsno datano data
Yizheng Qiu
Independent Director2.6yrsCN¥80.00kno data
Haifeng Wu
Director2.6yrsno datano data
Xia Fang Zhu
Supervisorno datano datano data

2.6yrs

Average Tenure

50yo

Average Age

Experienced Board: 600796's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 21:20
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Qianjiang Biochemical Co., Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yigong TaoChina Galaxy Securities Co., Ltd.